Dr. Thomas Patterson, professor and chief of the Division of Infectious Diseases, who is overseeing the local enrollment site for patients receiving remdesivir, said researchers are thrilled that the drug is showing such good results so early.
Newsroom
Dr. Thomas Patterson, professor and chief of the Division of Infectious Diseases, who is overseeing the local enrollment site for patients receiving remdesivir, said researchers are thrilled that the drug is showing such good results so early.